Frentizole in systemic lupus erythematosus. Current status.
D052160:Benzothiazoles; D056486:Chemical and Drug Induced Liver Injury / Q000453:epidemiology; D002986:Clinical Trials as Topic; D003106:Colon / Q000098:blood supply; D004359:Drug Therapy, Combination; D006801:Humans; D007373:Interinstitutional Relations; D007511:Ischemia / Q000139:chemically induced; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D010671:Phenylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010919:Placebos; D011241:Prednisone / Q000008:administration & dosage; D012107:Research Design; D013844:Thiazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors; D014481:United States
D052160:Benzothiazoles; D010671:Phenylurea Compounds; D010919:Placebos; D013844:Thiazoles; C013997:frentizole; D011241:Prednisone